文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

无创氧疗策略与成人急性低氧性呼吸衰竭全因死亡率的关联:系统评价与Meta分析

Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA · 2020-01-01
一句话结论成人急性低氧性呼吸衰竭中,与标准氧疗相比,头盔无创通气、面罩无创通气及经鼻高流量氧疗与较低死亡或插管风险相关,但证据确定性不一。

该网络Meta分析纳入25项随机临床试验(3804例成人急性低氧性呼吸衰竭患者),比较头盔无创通气、面罩无创通气、经鼻高流量氧疗与标准氧疗。与标准氧疗相比,头盔无创通气(RR 0.40,95%CrI 0.24-0.63;低确定性)和面罩无创通气(RR 0.83,95%CrI 0.68-0.99;中等确定性)与较低死亡风险相关;头盔无创通气(RR 0.26,95%CrI 0.14-0.46;低确定性)、面罩无创通气(RR 0.76,95%CrI 0.62-0.90;中等确定性)和经鼻高流量氧疗(RR 0.76,95%CrI 0.55-0.99;中等确定性)与较低插管风险相关。作者结论认为无创氧疗策略与较低死亡风险相关,但需进一步研究各策略的相对获益。

要点

  • 与标准氧疗相比,头盔无创通气与较低死亡风险相关(RR 0.40,95%CrI 0.24-0.63;绝对风险差 -0.19,95%CrI -0.37至-0.09;低确定性)。
  • 与标准氧疗相比,面罩无创通气与较低死亡风险相关(RR 0.83,95%CrI 0.68-0.99;绝对风险差 -0.06,95%CrI -0.15至-0.01;中等确定性)。
  • 与标准氧疗相比,头盔无创通气与较低插管风险相关(RR 0.26,95%CrI 0.14-0.46;绝对风险差 -0.32,95%CrI -0.60至-0.16;低确定性)。
  • 与标准氧疗相比,面罩无创通气(RR 0.76,95%CrI 0.62-0.90;中等确定性)和经鼻高流量氧疗(RR 0.76,95%CrI 0.55-0.99;中等确定性)均与较低插管风险相关。
  • 因缺乏盲法,插管结局的偏倚风险被评定为高;作者认为需进一步研究以更好理解各策略的相对获益。

适用人群与场景

  • 纳入成人急性低氧性呼吸衰竭患者,比较经鼻高流量氧疗、面罩无创通气、头盔无创通气或标准氧疗的随机临床试验。

研究设计与关键结果

  • 研究类型为系统评价与网络Meta分析,纳入25项随机临床试验(3804例参与者),主要结局为90天内全因死亡率,次要结局为30天内气管插管。
  • 与标准氧疗相比,头盔无创通气与较低死亡风险相关(RR 0.40,95%CrI 0.24-0.63;绝对风险差 -0.19,95%CrI -0.37至-0.09;低确定性),基于21项研究(3370例患者)。
  • 与标准氧疗相比,面罩无创通气与较低死亡风险相关(RR 0.83,95%CrI 0.68-0.99;绝对风险差 -0.06,95%CrI -0.15至-0.01;中等确定性),基于21项研究(3370例患者)。
  • 与标准氧疗相比,头盔无创通气与较低插管风险相关(RR 0.26,95%CrI 0.14-0.46;绝对风险差 -0.32,95%CrI -0.60至-0.16;低确定性),基于25项研究(3804例患者)。
  • 与标准氧疗相比,面罩无创通气与较低插管风险相关(RR 0.76,95%CrI 0.62-0.90;绝对风险差 -0.12,95%CrI -0.25至-0.05;中等确定性),基于25项研究(3804例患者)。
  • 与标准氧疗相比,经鼻高流量氧疗与较低插管风险相关(RR 0.76,95%CrI 0.55-0.99;绝对风险差 -0.11,95%CrI -0.27至-0.01;中等确定性),基于25项研究(3804例患者)。

证据类型、等级与局限

  • 证据类型为系统评价与网络Meta分析(贝叶斯框架),采用GRADE方法评定证据确定性。
  • 因缺乏盲法,插管结局的偏倚风险被评定为高。
  • 作者指出需进一步研究以更好理解各策略的相对获益。

对床旁实践的改变

  • 在成人急性低氧性呼吸衰竭患者中,与标准氧疗相比,头盔无创通气、面罩无创通气与较低死亡风险相关,经鼻高流量氧疗、面罩无创通气与头盔无创通气与较低插管风险相关。
  • 作者认为需进一步研究以更好理解各无创氧疗策略的相对获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Treatment with noninvasive oxygenation strategies such as noninvasive ventilation and high-flow nasal oxygen may be more effective than standard oxygen therapy alone in patients with acute hypoxemic respiratory failure.

OBJECTIVE: To compare the association of noninvasive oxygenation strategies with mortality and endotracheal intubation in adults with acute hypoxemic respiratory failure.

DATA SOURCES: The following bibliographic databases were searched from inception until April 2020: MEDLINE, Embase, PubMed, Cochrane Central Register of Controlled Trials, CINAHL, Web of Science, and LILACS. No limits were applied to language, publication year, sex, or race.

STUDY SELECTION: Randomized clinical trials enrolling adult participants with acute hypoxemic respiratory failure comparing high-flow nasal oxygen, face mask noninvasive ventilation, helmet noninvasive ventilation, or standard oxygen therapy.

DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted individual study data and evaluated studies for risk of bias using the Cochrane Risk of Bias tool. Network meta-analyses using a bayesian framework to derive risk ratios (RRs) and risk differences along with 95% credible intervals (CrIs) were conducted. GRADE methodology was used to rate the certainty in findings.

MAIN OUTCOMES AND MEASURES: The primary outcome was all-cause mortality up to 90 days. A secondary outcome was endotracheal intubation up to 30 days.

RESULTS: Twenty-five randomized clinical trials (3804 participants) were included. Compared with standard oxygen, treatment with helmet noninvasive ventilation (RR, 0.40 [95% CrI, 0.24-0.63]; absolute risk difference, -0.19 [95% CrI, -0.37 to -0.09]; low certainty) and face mask noninvasive ventilation (RR, 0.83 [95% CrI, 0.68-0.99]; absolute risk difference, -0.06 [95% CrI, -0.15 to -0.01]; moderate certainty) were associated with a lower risk of mortality (21 studies [3370 patients]). Helmet noninvasive ventilation (RR, 0.26 [95% CrI, 0.14-0.46]; absolute risk difference, -0.32 [95% CrI, -0.60 to -0.16]; low certainty), face mask noninvasive ventilation (RR, 0.76 [95% CrI, 0.62-0.90]; absolute risk difference, -0.12 [95% CrI, -0.25 to -0.05]; moderate certainty) and high-flow nasal oxygen (RR, 0.76 [95% CrI, 0.55-0.99]; absolute risk difference, -0.11 [95% CrI, -0.27 to -0.01]; moderate certainty) were associated with lower risk of endotracheal intubation (25 studies [3804 patients]). The risk of bias due to lack of blinding for intubation was deemed high.

CONCLUSIONS AND RELEVANCE: In this network meta-analysis of trials of adult patients with acute hypoxemic respiratory failure, treatment with noninvasive oxygenation strategies compared with standard oxygen therapy was associated with lower risk of death. Further research is needed to better understand the relative benefits of each strategy.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Ferreyro BL, Angriman F, Munshi L, et al. Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-analysis. JAMA. 2020. PMID: 32496521. doi:10.1001/jama.2020.9524

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。